In a landmark move set to redefine the future of healthcare in India, Fortis Healthcare announced the launch of the ‘Fortis Institute of Genomic Medicine’, a cutting-edge facility dedicated to leveraging genomic science for precision diagnostics and personalized treatment solutions across multiple specialties including oncology, cardiology, and neurology.
Backed by Fortis Healthcare’s advanced clinical ecosystem and the nationwide diagnostic reach of Agilus Diagnostics, the institute will unite a diverse team of molecular hematologists, oncologists, neurologists, pediatricians, pathologists, genomic scientists, bioinformaticians, and AI engineers — creating a powerful multidisciplinary hub for next-generation healthcare delivery.
Genomics: The Future of Personalized Medicine
Genomics — the study of an individual’s DNA — is rapidly transforming modern medical practice by moving away from the “one-size-fits-all” model of treatment. Fortis Healthcare’s new institute will spearhead this shift, especially in three critical specialties:
Onco-genomics: Enables doctors to decode the genetic blueprint of cancer, allowing for personalized and targeted therapies that are both more effective and less toxic than conventional chemotherapy.
Cardio-genomics: Supports early detection of inherited heart conditions such as sudden cardiac arrest, unexplained heart failure, and congenital defects, particularly for individuals with a family history of cardiac diseases.
Neuro-genomics: Provides gene-based diagnostic insights for complex neurological disorders including epilepsy, Parkinson’s disease, and rare neurodevelopmental syndromes, paving the way for tailored interventions.
Real-World Impact: Life-Changing Genomic Diagnoses
The Fortis Institute of Genomic Medicine is already delivering transformational results. Among the early success stories are a leukemia patient, initially bound for a bone marrow transplant, was spared the invasive procedure after a precise genetic diagnosis revealed a more targeted treatment option.
ALSO READ: Amid tariff war with US, China asks airlines to stop Boeing deliveries
Genomic screening detected a silent hereditary cancer risk in a woman, leading to life-saving early interventions for three family members.
A lung cancer patient was identified with a rare MET-ST7 fusion gene through Next-Generation Sequencing (NGS) technology, enabling treatment via specialized targeted therapy — a case of genomic science directly changing the course of care.
Leadership Speaks: A Vision for Future-Ready Healthcare
Anil Vinayak, Group Chief Operating Officer, Fortis Healthcare, called the launch “a strategic step forward,” stating: “By integrating genomics into our healthcare ecosystem, we are delivering on the promise of personalized, data-driven care. This initiative strengthens our clinical leadership and commitment to future-ready, technology-enabled healthcare, in line with Prime Minister Narendra Modi’s vision that Better Health today means a Better Future tomorrow.”
Dr. Ritu Garg, Chief Innovation and Growth Officer at Fortis Healthcare, added: “The Fortis Institute of Genomic Medicine represents our commitment to scalable, sustainable, and deeply impactful healthcare innovation. Genomics is not the future — it’s the present, and we are ensuring it reaches every patient who can benefit from it.”
Yash Rawat, Facility Director of Fortis Memorial Research Institute, Gurugram, highlighted the real-world significance: “Genomic testing is a game-changer, especially for early disease detection and treatment precision. Whether it’s a child with unexplained anemia, a cancer patient needing tailored therapy, or a family concerned about hereditary risk — genomics will reshape healthcare in India.”
Fortis’ Next Steps: AI-Powered Genomic Reporting & Health Registry
Fortis Healthcare has also announced plans to launch a Genomics-Informed Health Registry — aimed at setting new benchmarks in precision medicine.
India’s first AI-powered Genomic Reporting Platform, designed specifically for Indian clinicians, fully compliant with international standards including ACMG, AMP, and ASCO guidelines. The platform will streamline genetic data interpretation, making precision medicine more accessible and actionable in everyday medical practice.
The Fortis Institute of Genomic Medicine signals not just the future of healthcare, but a present where early diagnosis, prevention, and tailored treatments can become the new standard across India’s medical landscape.
